Product Images Glycopyrrolate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Glycopyrrolate NDC 65219-801 by Fresenius Kabi Usa, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This text provides information about a medication called Glycopyrrolate. It is available as an injection and contains 0.2 mg of the active ingredient per mL. The medication is indicated for intramuscular or intravenous use. The product is manufactured by Fresenius Kabi and is supplied in a single-dose vial containing 1 mL. It is important to note that the medication contains benzyl alcohol. The NDC number for this product is 65219-801-00, and there is a lot number/expiration date provided as well (LOT/EXP). This text does not contain any non-English characters and can be used to evaluate the medication.*
This is a description of an injection medication with the NDC number 65219-801-01 and RFID technology for tracking. The medication is a solution of 0.2 mg per mL and is not suitable for use in newborns. It can be administered intramuscularly or intravenously. The medication contains benzyl alcohol as a preservative and is available in single-dose vials of 1mL each. The usual dosage should be referred to in the package insert. The medication should be stored at a temperature of 20° to 25°C (68° to 77°F). The manufacturer of the medication is Fresenius Kabi located in Lake Zurich, IL. For more information, you can visit their website at www.fresenius-kabi.com/us.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.